Rapid brain autopsy: The Joseph and Kathleen Bryan Alzheimer's disease Research Center experience

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 6, 1997, Pages 615-618

  Hulette, Christine M ^a,b   Welsh Bohmer, Kathleen A ^a,b   Crain, Barbara ^b,c   Szymanski, Mari H ^a   Sinclaire, Nancy O ^a   Roses, Allen D ^a  

^a Bryan ADRC   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HOSPITAL PERSONNEL; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; NEUROPATHOLOGY; NURSE; PATIENT SELECTION; TERMINAL CARE; TIME OF DEATH; UNIVERSITY HOSPITAL;

AGED; ALZHEIMER DISEASE; AUTOPSY; BRAIN; COSTS AND COST ANALYSIS; DEMENTIA; FAMILY; HUMANS; MEDICAL RECORDS; NEUROLOGIC EXAMINATION; NORTH CAROLINA; TERMINAL CARE; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE BANKS;

EID: 0031010870     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Saunders AM, Strittmatter WJ, Hulette C, et al. Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993;43:1467-1472.
2. Hulette CM, Earl NL, Crain BJ. Evaluation of cerebral biopsies for the diagnosis of dementia. Arch Neurol 1992;49:28-31.
3. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzbeimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991;41:479-486.
4. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases. Ann Neurol. 1988;24:50-56.
5. Morris JC, McKeel DW, Fulling K, et al. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol. 1988;24:17-22.
6. Perry EK, Perry RH, Tomlinson BE. The influence of agonal state on some neurochemical activities in postmortem human brain tissue. Neurosci Lett. 1982;29:393-398.
7. Perry EK, Perry RH. Human brain neurochemistry - some postmortem problems. Life Sci. 1983;33:1733-1743.
8. Quig ME, Welsh KA, Plassman B, Murray MC, Breitner JCS. Detection of dementia in elderly populations: a neuropsychological assessment battery appropriate for epidemiological studies of dementia. International Neuropsychological Society. 1996. Abstract.
9. Silverman JM, Keefe RSE, Mohs RC, Davis KL. A study of the reliability of the family history method in genetic studies of Alzheimer's disease. Alzheimer Dis Assoc Disord. 1990;3:218-223.
10. Centers for Disease Control. Agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus. MMWR. 37(suppl S-4).
11. Brown P. Guidelines for high risk autopsy cases: special precautions for Creutzfeldt-Jakob disease. In: Hutchins G, ed. Autopsy Performance and Reporting. Northfield, Ill: College of American Pathologists; 1990:68-74.
12. Brown P, Wolff A, Gajdusek DC. A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creulzfeldt-Jakob disease. Neurology. 1990;40:887-890.
13. Mirra SS, Brownlee LM, Sumi SM, et al. The CERAD neuropathology protocol: observations on cases clinically diagnosed as probable Alzheimer's disease and controls. J Neuropathol Exp Neurol. 1989;48:334.
14. Hulette C, Mirra S, Wilkinson W, Heyman A, Fillenbaum G, Clark C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part IX: a prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology. 1995;45:1991-1995.
15. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathologica. 1991;82:239-259.
16. Dickson DW, Davies P, Mayeux R, et al. Diffuse Lewy body disease. Acta Neuropathol (Berl). 1987;75:8-15.
17. Smith MS, Schambra UB, Wilson KH, et al. Alpha-2 adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha-2 adrenergic receptor subtypes at four distinct levels. Mol Brain Res. 1995;34:109-117.